Thierry Fumeaux
Chief Tech/Sci/R&D Officer at Kinarus AG
Profile
Thierry Fumeaux is currently the Chief Medical Officer at Kinarus AG and Kinarus Therapeutics Holding AG.
He holds a Master's degree in Business Administration from the International Institute for Management Development.
Thierry Fumeaux active positions
| Companies | Position | Start |
|---|---|---|
Kinarus AG
 Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Chief Tech/Sci/R&D Officer | 2021-01-20 |
Former positions of Thierry Fumeaux
| Companies | Position | End |
|---|---|---|
| KINARUS THERAPEUTICS HOLDING AG | Chief Tech/Sci/R&D Officer | - |
Training of Thierry Fumeaux
| International Institute for Management Development | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Health Technology |
Kinarus Therapeutics Holding AG
 Kinarus Therapeutics Holding AG Pharmaceuticals: MajorHealth Technology Curatis Holding AG is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. The company was founded on April 8, 1997 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Thierry Fumeaux
